We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF

59 hedge funds and large institutions have $50.8M invested in ARK Genomic Revolution ETF in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 15

2% more funds holding

Funds holding: 58 → 59 (+1)

0.43% more ownership

Funds ownership: 19.37% → 19.8% (+0.43%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less capital inflows, than outflows

Capital inflows: $17.2M | Capital outflows: $17.8M

7% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 15

Holders
59
Holders Change
+1
Holders Change %
+1.72%
% of All Funds
1.31%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
18
Reduced
15
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ARKG Hedge Fund Activity: Q4 2018 in Review

59 of the 4,504 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q4 2018, worth a combined $50.8M — down 22% from $65.4M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of ARKG and 14 opened new positions — a net loss of 1 holder — while 15 trimmed existing stakes and 18 added.

The largest buyer was Arlington Capital Management, opening a new position worth an estimated $6.32M. The largest seller was Passport Capital, exiting entirely with an estimated $3.34M sold.

  • 59 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q4 2018, up from 58 in Q3 2018.
  • Funds reported $50.8M of ARK Genomic Revolution ETF stock for Q4 2018, down 22% quarter-over-quarter.
  • 14 funds opened new ARK Genomic Revolution ETF positions in Q4 2018 and 15 closed out, a net change of -1 holder.
  • The largest ARK Genomic Revolution ETF buyer in Q4 2018 was Arlington Capital Management, an estimated $6.32M added.
  • The largest ARK Genomic Revolution ETF seller in Q4 2018 was Passport Capital, an estimated $3.34M sold.

Based on aggregated 13F filings for Q4 2018.